Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)

SHA:605033 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 26, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,972	1,626	2,427	2,359	3,611	-
Market Cap Growth	100.73%	-32.98%	2.88%	-34.67%	-	-
Enterprise Value	2,707	1,176	2,126	2,060	3,339	-
Last Close Price	21.98	11.97	17.59	16.57	25.66	-
PE Ratio	116.64	44.13	42.16	16.26	28.72	-
PS Ratio	3.45	1.84	3.47	2.60	4.29	-
PB Ratio	2.59	1.45	2.18	2.17	3.74	-
P/TBV Ratio	2.88	1.62	2.35	2.20	3.77	-
P/FCF Ratio	370.45	13.38	18.51	137.78	-	-
P/OCF Ratio	13.93	5.80	7.25	18.66	-	-
EV/Sales Ratio	3.14	1.33	3.04	2.27	3.96	-
EV/EBITDA Ratio	84.99	29.93	33.34	13.73	24.63	-
EV/EBIT Ratio	-	62.31	49.56	15.31	27.13	-
EV/FCF Ratio	337.50	9.67	16.22	120.32	-	-
Debt / Equity Ratio	0.12	0.07	0.00	-	0.03	-
Debt / EBITDA Ratio	4.40	1.86	0.02	-	0.20	-
Debt / FCF Ratio	17.45	0.60	0.01	-	-	-
Asset Turnover	0.50	0.50	0.43	0.60	0.75	0.78
Inventory Turnover	3.76	2.12	1.18	1.04	1.27	1.43
Quick Ratio	2.17	1.21	1.39	1.69	1.14	0.73
Current Ratio	2.90	1.78	2.33	3.21	2.73	1.95
Return on Equity (ROE)	2.23%	3.29%	5.23%	14.13%	17.76%	19.20%
Return on Assets (ROA)	0.25%	0.66%	1.65%	5.56%	6.84%	7.32%
Return on Capital (ROIC)	0.34%	1.02%	2.44%	8.09%	10.66%	12.36%
Return on Capital Employed (ROCE)	0.50%	1.50%	3.50%	11.30%	12.00%	17.90%
Earnings Yield	0.86%	2.27%	2.37%	6.15%	3.48%	-
FCF Yield	0.27%	7.48%	5.40%	0.73%	-5.96%	-
Dividend Yield	0.92%	1.21%	0.85%	1.33%	0.74%	-
Payout Ratio	84.26%	76.62%	51.82%	18.38%	2.62%	0.89%
Buyback Yield / Dilution	-1.67%	-1.99%	1.29%	-22.93%	-9.27%	-1.93%
Total Shareholder Return	-0.76%	-0.78%	2.14%	-21.61%	-8.53%	-1.93%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.